Clinical Trials Logo

Clinical Trial Summary

The inferior mesenteric artery is the feeding vessel for tumours in the rectum. When performing surgery for these tumours, the surgeon can cut the vessel close to the aorta or after the vessel bifurcates to the superior rectal artery and the left colic artery. A close division is termed a high tie (and the other, a low tie) and might entail a better lymph node extraction, possibly removing metastasis, but can also lead to nerve damage and e.g. bowel dysfunction.

There is no clear evidence favouring either tie level, and large amounts of data are needed to establish superiority as any effects is likely to be small. One such method is to use national registries with prospectively collected data on e.g. level of tie and cancer relapse. However, it is not always easy to determine the level of tie while in the operating room and registries might also contain erroneous data.

In order to determine the validity of such data, comparisons to objective measures are needed. This study is an attempt to correlate radiographic imaging to the suggested tie level, as indicated by the surgeon in the operative report and by the nationwide Swedish Colorectal Cancer Registry. If the registry variable tie level has a high correlation with imagining, researchers can more reliably use the registry to establish the benefits and drawbacks with high tie in rectal cancer surgery.


Clinical Trial Description

The level of tie of the inferior mesenteric artery in rectal cancer surgery has been a controversy for decades. Proponents argue that lymph node harvest and bowel length can be improved, while detractors state that nerve damage is likely and that blood perfusion to an anastomosis is compromised. Few randomized clinical trials are available and these are underpowered for long-term outcomes, mainly stating no difference. Observational studies usually indicate no differences either, while lymph node harvest might be increased (though not concerning node metastasis). Long-term outcomes such as survival and recurrence have not been investigated with proper sample sizes to detect small effects. In effect, large scale trials are unlikely to be conducted, and only population-based studies are likely to accumulate adequate statistical power. One way would be to use nationwide registry data, such as the Swedish Colorectal Cancer Registry, in which tie level as well as recurrence and survival data are recorded. However, it is not always easy to determine the level of tie while in the operating room and registries might also contain erroneous data. In order to determine the validity of such data, comparisons to objective measures are needed. This study is an attempt to correlate radiographic imaging to the suggested tie level, as indicated by the surgeon in the operative report and by the nationwide Swedish Colorectal Cancer Registry. If the registry variable tie level has a high correlation with imagining, researchers can more reliably use the registry to establish the benefits and drawbacks with high tie in rectal cancer surgery.

The RAVAL study plans to include 100 patients from the University Hospitals in Umeå and Örebro, Sweden. Patients have been operated for rectal cancer and are contacted by telephone or at the postoperative visit, before their planned 1-year radiological follow-up. All patients sign informed consent for additional imaging with arterial phase contrast-enhanced computerized tomography (CT), performed at the same time as their planned follow-up (for detection of metastasis).

A dedicated study radiologist interprets the images, in conjunction with the routine preoperative imaging, and determines the tie level that was performed at the rectal cancer operation. Additional parameters such as vessel anatomy and the length of the artery stump are recorded. Clinical data from operative reports and histopathology will also be noted. When the study inclusion is completed, radiological determination of tie level will be compared with the surgeon's impression of tie level as well as the tie level in the Swedish Colorectal Cancer Registry.

The primary objective is to validate the level of tie in the registry, using sensitivity, specificity and Cohen's kappa. The secondary objectives include validation of tie level in comparison to operative reports, as well as artery stump length in relation to lymph node harvest, use of laparoscopy, and cancer recurrence (using appropriate techniques such as linear and Cox regression). The sample size is calculated per the primary objective, and assumes 90% sensitivity and specificity, which requires 86 and 58 patients, respectively, with a 10% margin of error. Attrition is expected, why 100 patients is determined to be adequate. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03875612
Study type Observational
Source Umeå University
Contact
Status Completed
Phase
Start date December 12, 2016
Completion date August 31, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT06380101 - Evaluating a Nonessential Amino Acid Restriction (NEAAR) Medical Food With Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer (LARC) N/A
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Recruiting NCT04323722 - Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Active, not recruiting NCT04088955 - A Digimed Oncology PharmacoTherapy Registry
Active, not recruiting NCT01347697 - Collagen Implant (Biological Mesh) Versus GM Flap for Reconstruction of Pelvic Floor After ELAPE in Rectal Cancer N/A
Recruiting NCT04495088 - Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer Phase 3
Withdrawn NCT03007771 - Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia Phase 1
Terminated NCT01347645 - Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer Phase 1/Phase 2
Not yet recruiting NCT03520088 - PROSPECTIVE CONTROLLED AND RANDOMIZED STUDY OF THE GENITOURINARY FUNCTION AFTER RECTAL CANCER SURGERY IN RELATION TO THE DISSECTION OF THE INFERIOR MESENTERIC VESSELS N/A
Recruiting NCT05556473 - F-Tryptophan PET/CT in Human Cancers Phase 1
Recruiting NCT04749381 - The Role of TCM on ERAS of Rectal Cancer Patients Phase 2
Enrolling by invitation NCT05028192 - Mitochondria Preservation by Exercise Training: a Targeted Therapy for Cancer and Chemotherapy-induced Cachexia
Recruiting NCT03283540 - Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence
Completed NCT04534309 - Behavioral Weight Loss Program for Cancer Survivors in Maryland N/A
Recruiting NCT05914766 - An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer N/A
Recruiting NCT04852653 - A Prospective Feasibility Study Evaluating Extracellular Vesicles Obtained by Liquid Biopsy for Neoadjuvant Treatment Response Assessment in Rectal Cancer
Recruiting NCT03190941 - Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients Phase 1/Phase 2
Completed NCT02810652 - Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection N/A
Terminated NCT02933944 - Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer Phase 1